enGene Holdings Inc. Warrants Share Price

enGene Holdings Inc. Warrants Share Price

ENGNW
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • About
  • Price history
  • FAQs

enGene Holdings Inc. Warrants Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

enGene Holdings Inc. Warrants Share Price Chart

$0.00
Please wait...

About enGene Holdings Inc. Warrants

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.

enGene Holdings Inc. Warrants Historical Data

DayOpenCloseChange %

FAQs on enGene Holdings Inc. Warrants Share Price

Can I buy enGene Holdings Inc. Warrants shares in India?

chevron-up
Yes. You can buy enGene Holdings Inc. Warrants in India by opening an international trading account.

What is the share price of enGene Holdings Inc. Warrants?

chevron-up
As on 13 Nov '25, the share price of enGene Holdings Inc. Warrants ENGNW is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.

What is the 5 year returns of enGene Holdings Inc. Warrants?

chevron-up
The 5 year returns of enGene Holdings Inc. Warrants is as on 13 Nov '25.

What are the high & low stock price of enGene Holdings Inc. Warrants today?

chevron-up
enGene Holdings Inc. Warrants stock price hit a high of $0.00 and low of $0.00 as on 13 Nov '25.

What is the 52-week high and low of enGene Holdings Inc. Warrants stock?

chevron-up
The 52-week high of enGene Holdings Inc. Warrants stock is $0.00, while the 52-week low is $0.00 as on 13 Nov '25.